Quantcast
Last updated on April 19, 2014 at 9:20 EDT

Latest Glaucoma valve Stories

2014-02-04 08:35:06

Industry Leaders To Hear From an Important New Voice In The Fight Against Glaucoma MIAMI, Feb. 4, 2014 /PRNewswire/ -- InnFocus, Inc., today announced that it will participate in the Glaucoma 360 New Horizons Forum on Friday, February 7(th), 2014 at The Palace Hotel, in San Francisco. The event is presented by the Glaucoma Research Foundation and brings together key clinical, industry, financial and regulatory leaders, in a unique exchange on research innovation and advances in...

2014-01-14 16:25:59

WASHINGTON, N.C., Jan. 14, 2014 /PRNewswire/ -- Precision Eye Care is proud to announce their support of Glaucoma Awareness Month, taking place this January. Glaucoma is the second leading cause of blindness; and in the United State alone, it affects more than 2.7 million people over the age of 40. The National Eye Institute projects this number will grow to 4.2 million by 2030. Experts suggest a major reason for the large number of glaucoma sufferers is that most people don't realize...

2013-01-25 23:01:50

The Boston Eye Group announced today it has implanted the first device allowing remote intraocular pressure monitoring in patients with Glaucoma. Glaucoma is the second most common cause of blindness in the United States. Brookline, MA (PRWEB) January 25, 2013 Glaucoma is characterized by slow, painless loss of vision due to optic nerve damage mostly related to an elevated eye pressure. Until now, doctors have relied on in-office methods to measure the eye pressure.This requires a visit to...

2013-01-05 05:02:10

Hudson Valley Ambulatory Surgery performs first procedure of its kind in the region Middletown, NY (PRWEB) January 04, 2013 Eye Surgeon Dr. Severin Palydowycz of Hudson Valley Ambulatory Surgery(HVAS) announced that he is providing the iStent® Trabecular Micro-Bypass Stent as a treatment option to reduce eye pressure for patients with both cataracts and glaucoma. Dr. Palydowycz performed the first cataract surgery to include the iStent in the Hudson Valley. The iStent is FDA-approved...

2012-12-03 12:27:55

BRECKSVILLE, Ohio, Dec. 3, 2012 /PRNewswire/ -- Eye surgeons, Dr. William Wiley and Dr. Shamik Bafna of Cleveland Eye Clinic announced that they are providing the iStent Trabecular Micro-Bypass Stent as a treatment option to reduce eye pressure for patients with both cataracts and glaucoma. The iStent is used in conjunction with cataract surgery to reduce eye pressure in adult patients with mild-to-moderate open-angle glaucoma currently being treated with glaucoma medicine. In clinical...

2012-03-07 13:49:33

A new paradigm to explain glaucoma is rapidly emerging, and it is generating brain-based treatment advances that may ultimately vanquish the disease known as the "sneak thief of sight." A review now available in Ophthalmology, the journal of the American Academy of Ophthalmology, reports that some top researchers no longer think of glaucoma solely as an eye disease. Instead, they view it as a neurologic disorder that causes nerve cells in the brain to degenerate and die, similar to what...

2009-07-13 15:56:26

The overall number of glaucoma surgical procedures appears to be increasing, but payments by Medicare for the procedures have been decreasing, according to a report in the July issue of Archives of Ophthalmology, one of the JAMA/Archives journals.Glaucoma is one of the leading causes of blindness worldwide and currently affects more than 2 million people in the United States, according to background information in the article. "Management and treatment of glaucoma can be costly, and it has...

2009-03-12 07:00:00

Leading Glaucoma Experts are Working Together to Provide Tips to Help Prevent Vision Loss as Glaucoma Prevalence is Rising Rapidly Across the Globe NEW YORK, March 12 /PRNewswire/ -- On the second annual World Glaucoma Day (March 12), leading global glaucoma experts are working together to help educate patients diagnosed with glaucoma and those who may be at risk for the condition. Glaucoma is a worldwide epidemiological challenge affecting approximately four percent of the global population...

2009-02-19 12:15:00

- Clinical Performance Indicates a 40% Reduction of Intraocular Pressure at Two Years - WALTHAM, Mass., Feb. 19 /PRNewswire/ -- SOLX, Inc. announced today that it has surpassed 1000 implantation procedures with its proprietary SOLX Gold Shunt(R), a drainage device that reduces intraocular pressure (IOP) for the treatment of glaucoma. "This is a significant milestone," said Doug Adams, President and Founder of SOLX, "as it validates the importance of the Gold Shunt in the treatment of...

2008-09-09 12:00:42

NEW YORK, MONTREAL, and SAN DIEGO, CA, Sept. 9 /PRNewswire-FirstCall/ -- Canadian Bio Med Systems Inc., a wholly owned subsidiary of ICBS Limited (OTCPK: ICBT), is pleased to announced a revolutionary new treatment for Glaucoma being developed in conjunction with the university of Arizona. An exciting new drug is currently under development by Canadian Bio Med Systems, Inc. with their partner Ocular Therapeutics Inc, of San Diego, (CBMS) which may changed the paradigm of glaucoma therapy....